Immediate Versus Delayed Treatment of Odontogenic Infections

Sponsor
Boston Children's Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04057014
Collaborator
(none)
0
3
1

Study Details

Study Description

Brief Summary

The objective of this study is to compare the physiologic resolution of dental infections between immediate tooth extraction (control group) and administration of systemic antibiotics and delayed extraction (study groups 1 and 2). A secondary objective is two compare two different antibiotic regimens in the delayed extraction groups (study group 1 and 2).

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This is a prospective partially randomized clinical trial. Patients 2-11 years old who have a vestibular swelling associated with an odontogenic infection are being studied. Subjects will self-select into the control or study group. All subjects will be offered to have the tooth extracted on the day of diagnosis, and if this treatment is chosen they will join the control group (group 1). Subjects who defer treatment will be placed on amoxicillin and will be placed into the study group. The study group will be randomized into two parallel study groups that either have average dose antibiotics for 10 days (group 2), or maximum dose antibiotics for 5 days (group 3).

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective partially randomized parallel study groups clinical trial investigation.Prospective partially randomized parallel study groups clinical trial investigation.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Study of Immediate Versus Delayed Treatment of Odontogenic Infections
Anticipated Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Oct 2, 2020
Actual Study Completion Date :
Oct 2, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Extraction Only

Immediate extraction of infected tooth without antibiotic prescription.

Procedure: Tooth extraction
Removal of infected tooth on first day of study, this approach does not require an antibiotic drug.
Other Names:
  • Exodontia
  • Experimental: Average Dose Antibiotic

    Average dose antibiotic therapy(25 mg/kg/day in divided doses every 12 hours (maximum 875 mg/dose)) for 10 days and receive tooth extraction on day 10 (25 patients). (*given the average weight of a 12 year old is 45 kilos, we do not expect that we will reach the maximum dose in this group)

    Drug: Amoxicillin
    Antibiotic given at different dosages and durations.
    Other Names:
  • Amoxil
  • Procedure: Tooth extraction
    Removal of infected tooth on first day of study, this approach does not require an antibiotic drug.
    Other Names:
  • Exodontia
  • Experimental: High Dose Antibiotic

    High dose antibiotic therapy (45 mg/kg/day in divided doses every 12 hours (maximum 875 mg/dose)) for 5 days and receive tooth extraction on day 10 (25 patients)

    Drug: Amoxicillin
    Antibiotic given at different dosages and durations.
    Other Names:
  • Amoxil
  • Procedure: Tooth extraction
    Removal of infected tooth on first day of study, this approach does not require an antibiotic drug.
    Other Names:
  • Exodontia
  • Outcome Measures

    Primary Outcome Measures

    1. Change in diagnosis [Infection will be monitored at days 0, 5, 10 and 20.]

      Tooth infection not clinically detectable

    Secondary Outcome Measures

    1. Measure of pediatric oral health-related quality of life: the POQL [Survey of quality of life at days 0, 5, 10 and 20.]

      Quality of life compared between arms. Pediatric Oral Health Quality of Life (PQOL) clustered into four dimensions - Physical Functioning, Role Functioning, Social Functioning and Emotional Functioning. It was designed to be used in high risk, low resource, populations with greater health disparities. Specifically we are looking significant difference between the study groups that is at least 2 standard errors from the control group. If there are not two deviations to discriminate between scales would indicate a non-significant finding.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 11 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients who present to the dental clinic or Boston Children's Hospital emergency room

    • Odontogenic origin associated with a primary tooth and limited to the buccal vestibule only

    • Ages of 2-11 years old

    • Primary Caregiver present

    • English speaking

    • American Society of Anesthesiologists (ASA) classification of I

    • None or current systemic antibiotic therapy regimen < 24 hours

    • Able to take medication orally

    • Those patients who choose to participate in the study

    Exclusion Criteria:
    • Infection that has spread beyond the buccal vestibule, or not detectable

    • Infection is associated with a permanent adult tooth

    • Ages of <2 years old or >11 years old

    • American Society of Anesthesiologists classification of II or greater or poor general health.

    • Renal impairment

    • Immunosuppressive disease

    • Recent antibiotic therapy in the last 1 to 30 days

    • Allergy to penicillin

    • Unable to take oral medications

    • Decline participation

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Boston Children's Hospital

    Investigators

    • Principal Investigator: Keri Discepolo, DDS, Boston Children's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Keri Discepolo, Associate Dentist, Boston Children's Hospital
    ClinicalTrials.gov Identifier:
    NCT04057014
    Other Study ID Numbers:
    • P00030880
    First Posted:
    Aug 14, 2019
    Last Update Posted:
    Oct 6, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Keri Discepolo, Associate Dentist, Boston Children's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 6, 2020